Prevalence of germline TP53 mutation among early onset middle eastern breast cancer patients

ConclusionsTP53 germline mutation screening detects a clinically meaningful risk of early onset BC from this ethnicity and should be considered in all early onset BC regardless of the family history of cancer, especially in young patients that are negative forBRCA mutations.
Source: Hereditary Cancer in Clinical Practice - Category: Cancer & Oncology Source Type: research